Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens

INTRODUCTION: Dolutegravir/lamivudine (DTG/3TC) is a 2-drug regimen for HIV-1 treatment with long-term efficacy and good tolerability comparable to 3- or 4-drug regimens. This study evaluated DTG/3TC cost versus other standard single-tablet regimens during its first year of approval. METHODS: This r...

Descripción completa

Detalles Bibliográficos
Autores principales: Priest, Julie, Germain, Guillaume, Laliberté, François, Duh, Mei Sheng, Mahendran, Malena, Fakih, Iman, Oglesby, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505118/
https://www.ncbi.nlm.nih.gov/pubmed/37552426
http://dx.doi.org/10.1007/s40121-023-00848-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505118/
https://www.ncbi.nlm.nih.gov/pubmed/37552426
http://dx.doi.org/10.1007/s40121-023-00848-4

Ejemplares similares